Research Article
The Expression of IL-6, TNF-α, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Table 3
Baseline characteristics according to viral status.
| | | VN | VP | CI |
| | Male, | 12 (60%) | 16 (62%) | 9 (60%) | | Current smoker | 6 (30%) | 9 (35%) | 6 (40%) | | Total cigarette consumption (pack years) | 59 | 61
| 58
| | Prior COPD hospitalization | 6 (30%) | 11 (42%) | 6 (40%) | | Influenza vaccinations | 16 (80%) | 6 (23%) | 7 (46%) | | Exacerbation symptom present ≥ 4 days | 8 (40%) | 18 (70%) | 5 (33%) | | Symptoms at entry | | | | | Fever | 3 (15%) | 10 (38%) | 6 (40%) | | Sore throat | 4 (20%) | 12 (46%) | 7 (46%) | | Runny or congested nose | 9 (45%) | 17 (65%) | 9 (60%) | | Discolored sputum | 8 (40%) | 16 (62%) | 8 (53%) | | Treatment | | | | | Oxygen therapy | 2 (10%) | 3 (12%) | 3 (20%) | | Antibiotic therapy | 11 (55%) | 15 (58%) | 8 (53%) | | Corticosteroids | 5 (25%) | 6 (23%) | 6 (40%) |
|
|
The difference between the two groups was analyzed by Chi-square test.
versus the virus positive AECOPD.
|
